> top > docs > PubMed:22788263 > annotations

PubMed:22788263 JSONTXT

Annnotations TAB JSON ListView MergeView

Allie

Id Subject Object Predicate Lexical cue
SS1_22788263_2_0 229-269 expanded denotes Attention-deficit hyperactivity disorder
SS2_22788263_2_0 271-275 abbr denotes ADHD
SS1_22788263_6_0 706-733 expanded denotes cost-effectiveness analysis
SS2_22788263_6_0 735-738 abbr denotes CEA
SS1_22788263_6_1 767-794 expanded denotes guanfacine extended release
SS2_22788263_6_1 796-799 abbr denotes GXR
SS1_22788263_10_0 1254-1289 expanded denotes Clinical Global Impression-Severity
SS2_22788263_10_0 1291-1296 abbr denotes CGI-S
SS1_22788263_15_0 2121-2155 expanded denotes probabilistic sensitivity analysis
SS2_22788263_15_0 2157-2160 abbr denotes PSA
SS1_22788263_18_0 2599-2635 expanded denotes incremental cost-effectiveness ratio
SS2_22788263_18_0 2637-2641 abbr denotes ICER
AE1_22788263_2_0 SS1_22788263_2_0 SS2_22788263_2_0 abbreviatedTo Attention-deficit hyperactivity disorder,ADHD
AE1_22788263_6_0 SS1_22788263_6_0 SS2_22788263_6_0 abbreviatedTo cost-effectiveness analysis,CEA
AE1_22788263_6_1 SS1_22788263_6_1 SS2_22788263_6_1 abbreviatedTo guanfacine extended release,GXR
AE1_22788263_10_0 SS1_22788263_10_0 SS2_22788263_10_0 abbreviatedTo Clinical Global Impression-Severity,CGI-S
AE1_22788263_15_0 SS1_22788263_15_0 SS2_22788263_15_0 abbreviatedTo probabilistic sensitivity analysis,PSA
AE1_22788263_18_0 SS1_22788263_18_0 SS2_22788263_18_0 abbreviatedTo incremental cost-effectiveness ratio,ICER

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 229-269 HP_0007018 denotes Attention-deficit hyperactivity disorder
T2 229-246 HP_0007018 denotes Attention-deficit
T3 247-260 HP_0000752 denotes hyperactivity
T4 289-309 HP_0000708 denotes psychiatric disorder

NEUROSES

Id Subject Object Predicate Lexical cue
T1 22-32 CHEBI_5558 denotes guanfacine
T2 767-777 CHEBI_5558 denotes guanfacine
T3 349-352 PATO_0000011 denotes age
T4 349-352 CHEBI_84123 denotes age
T8 1203-1209 PATO_0000461 denotes normal
T9 1431-1436 PATO_0001177 denotes blind
T10 1794-1798 CHEBI_24433 denotes rest
T11 1812-1818 PATO_0001309 denotes period
T12 2220-2228 PATO_0001309 denotes duration
T13 2932-2938 PATO_0001309 denotes period
T14 1842-1846 CHEBI_23888 denotes drug
T15 2407-2411 CHEBI_23888 denotes drug
T20 2096-2107 PATO_0000085 denotes sensitivity
T21 2135-2146 PATO_0000085 denotes sensitivity
T22 2673-2684 PATO_0000085 denotes sensitivity
T23 2157-2160 CHEBI_61599 denotes PSA
T24 2940-2943 CHEBI_61599 denotes PSA
T25 2557-2560 CHEBI_43739 denotes led
T26 2630-2635 PATO_0001038 denotes ratio
T27 2630-2635 PATO_0001470 denotes ratio
T28 3384-3393 PATO_0000152 denotes threshold